Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis

Iron deficiency (ID) is a common co‐morbidity in patients with heart failure (HF) and has been suggested to be associated with poor prognosis. Recently completed double‐blind randomised controlled trials (RCTs) studying HF patients with ID have shown improvements in functional capacity, symptoms and quality of life when treated with i.v. ferric carboxymaltose (FCM). This individual patient data meta‐analysis investigates the effect of FCM vs. placebo on recurrent hospitalisations and mortality in HF patients with ID.

• Publication year

  2018

• Venue

  European Journal of Heart Failure

• Publication date

  2018-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ejhf.823PMID 28436136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis

  2017cited by this paper
• The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications

  2016cited by this paper
• Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure

  2016cited by this paper
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2016cited by this paper
• The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials

  2016cited by this paper
• Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?

  2015cited by this paper
• Iron deficiency and cardiovascular disease

  2015cited by this paper
• Rationale and design of the CONFIRM‐HF study: a double‐blind, randomized, placebo‐controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency

  2014cited by this paper
• Iron i.v. in heart failure: ready for implementation?

  2014cited by this paper
• Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†

  2014cited by this paper
• Iron deficiency in a multi‐ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis

  2014cited by this paper
• Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved

  2014cited by this paper
• Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.

  2014cited by this paper
• Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis.

  2013cited by this paper
• EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot)

  2013cited by this paper
• Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

  2013cited by this paper
• Iron deficiency in chronic heart failure: an international pooled analysis.

  2013cited by this paper
• IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.

  2013cited by this paper
• Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta‐analysis

  2012cited by this paper
• Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

  2011cited by this paper
• Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.

  2011cited by this paper
• Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches

  2011cited by this paper
• Ferric carboxymaltose in patients with heart failure and iron deficiency.

  2009cited by this paper
• Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

  2009cited by this paper
• Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

  2008cited by this paper
• Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

  2007cited by this paper
• A precious metal: Iron, an essential nutrient for all cells

  2006cited by this paper
• Non-cardiac comorbidities in chronic heart failure

  2006cited by this paper
• Iron-Deficiency Anemia: Reexamining the Nature and Magnitude of the Public Health Problem Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship 1,2

  2001cited by this paper
• Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation.

  1999cited by this paper

• Iron deficiency in patients with chronic thromboembolic pulmonary hypertension: prevalence, pathogenesis, and diagnostic criteria

  2026cites this paper
• Changes in Cardiac Function and Exercise Capacity Following Ferric Carboxymaltose Administration in HFrEF Patients with Iron Deficiency

  2025influential citation
• Ferric carboxymaltose in therapy of patients with malignant neoplasms complicated by anemia and iron deficiency. Literature review and clinical observations

  2025cites this paper
• Signal detection of ferric carboxymaltose-induced serious adverse events: disproportionality analysis of FAERS and VigiBase data and systematic review of case reports

  2025cites this paper
• Intravenous Iron in Heart Failure Patients With Iron Deficiency: A Meta‐Analysis of Randomized Controlled Trials

  2025cites this paper
• Prevalence and Adverse Outcomes of Iron Deficiency in Heart Failure

  2025cites this paper
• Review of the Scientific and Educational Conference “Multidisciplinary approach in hematology and oncology in the Moscow Region”. May 22, 2025

  2025cites this paper
• Management of patients with iron deficiency anemia in the context of primary health care. Guidelines

  2025cites this paper
• Impact of Intravenous Iron Replacement Therapy on Healthcare Costs for Patients with Iron Deficiency Anemia in the USA: A Retrospective Analysis

  2025cites this paper
• Iron Deficiency in Heart Failure: Cellular Mechanisms and Therapeutic Implications

  2025cites this paper
• Comparison of iron deficiency markers in patients with advanced heart failure.

  2025cites this paper
• Practical Anemia Bundle and Hemoglobin Recovery in Critical Illness

  2025cites this paper
• Heart failure with reduced ejection fraction.

  2025cites this paper
• Clinical Outcomes of Intravenous Iron Therapy in Systolic Heart Failure Patients Receiving SGLT2 Inhibitors.

  2025cites this paper
• Ferric Carboxymaltose in Heart Failure With Iron Deficiency-Reply.

  2025cites this paper
• Rationale and design of the FAIR‐HF2‐DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure

  2025cites this paper
• Prevalence and Spectrum of Iron Deficiency in Heart Failure Patients in a Tertiary Cardiac Centre in Nepal

  2024cites this paper
• Increasing rates of screening and treatment of iron deficiency in ambulatory patients with heart failure with reduced ejection fraction: a quality improvement cohort study

  2024cites this paper
• Iron deficiency and supplementation in heart failure

  2024cites this paper
• Defining Iron Deficiency in Heart Failure: Importance of Transferrin Saturation.

  2024cites this paper
• Influence of iron deficiency definition on the efficacy of intravenous iron in heart failure: a meta-analysis of randomized trials.

  2024cites this paper
• Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

  2024cites this paper
• A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China

  2024cites this paper
• Prognostic Role of Tissue Iron Deficiency Measured by sTfR Levels in Heart Failure Patients without Systemic Iron Deficiency or Anemia

  2024cites this paper
• Iron Deficiency in Patients with Left Ventricular Assist Devices

  2024cites this paper
• HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients

  2024cites this paper
• Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure

  2024cites this paper
• Interaction between systemic iron parameters and left ventricular structure and function in the preserved ejection fraction population: a two-sample bidirectional Mendelian randomization study.

  2024cites this paper
• Relationship of Iron Deficiency, Anemia and Combination of Iron Deficiency With Anemia With Severity of Manifestations of Chronic Heart Failure. Additional Analysis of the Study "Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)".

  2024cites this paper
• Impact of Intravenous Iron in patients with heart failure and Iron Deficiency: an updated Meta-analysis of Randomized controlled trials

  2024cites this paper
• The association of iron deficiency with right ventricular dysfunction in Africans with heart failure

  2024cites this paper
• Identification of three mechanistic pathways for iron-deficient heart failure

  2024cites this paper
• Retrospective analysis of ferrotherapy methodology in patients with chronic heart failure and chronic kidney disease

  2024cites this paper
• Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients

  2024influential citation
• Pharmacotherapy in the heart transplant recipient: A primer for nurse clinicians and pharmacists

  2024cites this paper
• Effectiveness of antianemic therapy for patients with severe iron deficiency anemia

  2024cites this paper
• Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database Analysis

  2024cites this paper
• Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure

  2024cites this paper
• 2024 Clinical practice guidelines for Chronic heart failure

  2024cites this paper
• Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies.

  2024cites this paper
• Anemia and heart failure

  2024cites this paper
• Iron Deficiency and its Relationship with Chronic Heart Failure- A Review.

  2024cites this paper
• Iron-deficiency Anemia Treatment with Ferric Carboxymaltose: A Real-world Quasi-experimental Study from Bangladesh

  2024cites this paper
• Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency: JACC State-of-the-Art Review.

  2024cites this paper
• Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis

  2024cites this paper
• Rationale and design of a prospective randomized study of the effect of ferric carboxymaltose therapy on quality of life and clinical picture of heart failure with preserved ejection fraction in patients with iron deficiency

  2024cites this paper
• Ferric carboxymaltose reduces the burden of arrhythmic events in heart failure with reduced ejection fraction: the role of the non-invasive arrhythmic biomarkers.

  2024cites this paper
• Benefits of intravenous iron supplementation in heart failure

  2024cites this paper
• Baseline Characteristics of Patients in the Randomized Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency: HEART-FID Trial.

  2023cites this paper
• Red blood cell count and risk of adverse outcomes in patients with mildly reduced left ventricular ejection fraction

  2023cites this paper
• Treating Iron Deficiency in Heart Failure.

  2023cites this paper
• ферокінетичних показників

  2023cites this paper
• Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials

  2023cites this paper
• Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function

  2023cites this paper
• Treating Iron Deficiency (ID) Anemia in Heart Failure (HF) Patients with IV Iron: A Meta-Analysis

  2023cites this paper
• Understanding the Interplay between Iron Deficiency and Congestive Heart Failure: A comprehensive review

  2023cites this paper
• Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?

  2023cites this paper
• Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch

  2023cites this paper
• Ironing out the wrinkles: Unanswered questions in intravenous iron repletion in heart failure

  2023cites this paper
• [Iron deficiency in cardiac surgery patients and the possibility of its correction at the preoperative stage].

  2023cites this paper
• Iron Repletion for Patients with Heart Failure and Kidney Dysfunction.

  2023cites this paper
• Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study

  2023cites this paper
• Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease

  2023cites this paper
• Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy

  2023cites this paper
• Iron Deficiency in Korean Patients With Heart Failure

  2023cites this paper
• Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis

  2023cites this paper
• Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta‐analysis

  2023cites this paper
• The role of iron deficiency in heart failure

  2023cites this paper
• Association of iron therapy with incidence of chronic kidney disease

  2023cites this paper
• Iron deficiency states in cardiovascular diseases: impact on prognosis and features of correction

  2023cites this paper
• Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America.

  2023cites this paper
• Is red distribution width a valid tool to predict impaired iron transport in heart failure?

  2023cites this paper
• Preemptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction.

  2023cites this paper
• Iron Deficiency in Pulmonary Vascular Disease: Pathophysiological and Clinical Implications.

  2023cites this paper
• Iron deficiency in heart failure across the spectrum of left ventricular ejection fraction: dotting the i's.

  2023cites this paper
• Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis

  2023cites this paper
• Intravenous iron infusion in patients with heart failure: a systematic review and study‐level meta‐analysis

  2023influential citation
• Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation

  2023cites this paper
• Management of heart failure in patients with kidney disease - updates from the 2021 ESC guidelines.

  2023cites this paper
• Factors associated with iron deficiency in heart failure

  2023cites this paper
• How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome

  2023cites this paper
• Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE‐HF trial

  2023cites this paper
• Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review

  2023cites this paper
• Role of Iron Deficiency in Heart Failure—Clinical and Treatment Approach: An Overview

  2023cites this paper
• How to Change the Medical History of Patients with Heart Failure and Recurrent Hospitalizations?

  2023cites this paper
• The peculiarities of changes in myocardial electrical activity and heart rate variability in patients with coronary artery disease depending on the stage of concomitant iron deficiency

  2023cites this paper
• Sodium–Glucose Transporter 2 (SGLT2) Inhibitors and Iron Deficiency in Heart Failure and Chronic Kidney Disease: A Literature Review

  2023cites this paper
• Early improvement of global longitudinal strain after iron deficiency correction in heart failure with reduced ejection fraction

  2023cites this paper
• Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure

  2023cites this paper
• Benefits of intravenous iron supplementation in patients with heart failure: mounting evidence and open questions

  2023cites this paper
• Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial‐IRON trial

  2023cites this paper
• Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N.

  2023cites this paper
• Intravenous Iron for Heart Failure: Updated Systematic Review and Meta-Analysis

  2023cites this paper
• Characteristics of clinical and laboratory parameters in patients with chronic heart failure of elderly and senile age with iron deficiency

  2023cites this paper
• Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure.

  2023cites this paper
• The Impact of Iron Deficiency on Disease Severity and Myocardial Function in Cardiac Amyloidosis

  2023cites this paper
• Deficiencia de hierro en enfermedad renal crónica

  2023cites this paper
• An overview of iron deficiency anaemia and its management options

  2023cites this paper
• Documento de consenso sobre la anemia y déficit de hierro en insuficiencia cardiaca: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) de la Sociedad Interamericana de Cardiología (SIAC)

  2023cites this paper
• New possibilities of pathogenetic correction of anemia in chronic heart failure

  2023cites this paper